LiberaBio

📍 Santiago de Compostela, Spain🗓 Founded 2018👥 9 employees💰 Last funded Dec 2021
Biotechnology Research🌐 liberabio.com
Website LinkedIn
LiberaBio is a preclinical stage biotech that develops new oncology treatments based on the proprietary MPN technology. This nanotechnology actively targets tumor and metastatic cells and delivers small and large molecules to on-surface or intracellular targets. The company is creating new treatments by delivering novel antibodies targeting intracellular oncoproteins.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2018
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
1
Spain
1
Frequently asked questions
Who invested in LiberaBio?
LiberaBio has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did LiberaBio last raise funding?
The most recent investment in LiberaBio recorded on gritt.io was in December 2021.
When was LiberaBio founded?
LiberaBio was founded in 2018.
What industry is LiberaBio in?
LiberaBio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is LiberaBio based?
LiberaBio is headquartered in Santiago de Compostela, Spain.